Patients with neutropenia are exposed to a high risk for infections in which fever is often the unique symptom [1]. Systemic infections remain the main cause of mortality in these patients therefore, the policy for infection management is to promptly administer empirical antibiotic therapy in order to avoid the increased risk of mortality related to the treatment delay [2]. However, microbiological diagnostic tests are not sufficiently rapid, sensitive or specific to indentify the microbial causes of fever, and a considerable number of patients suffer febrile episodes over a prolonged period without a definite microbiological etiology
Despite advances in the diagnosis and treatment of infections diseases, sepsis and ensuing multiorga...
Background: Infectious diseases still remain a challenge despite great advances in medicine. It is o...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
Patients with neutropenia are exposed to a high risk for infections in which fever is often the uniq...
Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of th...
The novel inflammatory marker procalcitonin (PCT) was assessed as an index of infection in patients ...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
In order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutropenia from...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of th...
ABSTRACTIn order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutrope...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
Abstract Background ...
Background. Infectious complications cause significant mortality in children with oncological diseas...
An ideal marker for bacterial infections should allow an early diagnosis, inform about the course an...
Despite advances in the diagnosis and treatment of infections diseases, sepsis and ensuing multiorga...
Background: Infectious diseases still remain a challenge despite great advances in medicine. It is o...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
Patients with neutropenia are exposed to a high risk for infections in which fever is often the uniq...
Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of th...
The novel inflammatory marker procalcitonin (PCT) was assessed as an index of infection in patients ...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
In order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutropenia from...
Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological and clinica...
Procalcitonin is a marker of severe bacterial infections in non-neutropenic patients. The goal of th...
ABSTRACTIn order to assess the diagnostic value of procalcitonin, 158 patients with febrile neutrope...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...
Abstract Background ...
Background. Infectious complications cause significant mortality in children with oncological diseas...
An ideal marker for bacterial infections should allow an early diagnosis, inform about the course an...
Despite advances in the diagnosis and treatment of infections diseases, sepsis and ensuing multiorga...
Background: Infectious diseases still remain a challenge despite great advances in medicine. It is o...
Background: Management of febrile neutropenic episodes (FE) is challenged by lacking microbiological...